These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation. Mitchell DA; Taylor PR; Cook HT; Moss J; Bygrave AE; Walport MJ; Botto M J Immunol; 1999 May; 162(10):5676-9. PubMed ID: 10229798 [TBL] [Abstract][Full Text] [Related]
4. Restoration of C1q levels by bone marrow transplantation attenuates autoimmune disease associated with C1q deficiency in mice. Cortes-Hernandez J; Fossati-Jimack L; Petry F; Loos M; Izui S; Walport MJ; Cook HT; Botto M Eur J Immunol; 2004 Dec; 34(12):3713-22. PubMed ID: 15517607 [TBL] [Abstract][Full Text] [Related]
5. C1q knock-out mice for the study of complement deficiency in autoimmune disease. Botto M Exp Clin Immunogenet; 1998; 15(4):231-4. PubMed ID: 10072632 [TBL] [Abstract][Full Text] [Related]
12. C1q deficiency and autoimmunity: the effects of genetic background on disease expression. Mitchell DA; Pickering MC; Warren J; Fossati-Jimack L; Cortes-Hernandez J; Cook HT; Botto M; Walport MJ J Immunol; 2002 Mar; 168(5):2538-43. PubMed ID: 11859149 [TBL] [Abstract][Full Text] [Related]
13. Reconstitution of the complement function in C1q-deficient (C1qa-/-) mice with wild-type bone marrow cells. Petry F; Botto M; Holtappels R; Walport MJ; Loos M J Immunol; 2001 Oct; 167(7):4033-7. PubMed ID: 11564823 [TBL] [Abstract][Full Text] [Related]
14. Infiltrating dendritic cells contribute to local synthesis of C1q in murine and human lupus nephritis. Castellano G; Trouw LA; Fiore N; Daha MR; Schena FP; van Kooten C Mol Immunol; 2010 Jul; 47(11-12):2129-37. PubMed ID: 20417969 [TBL] [Abstract][Full Text] [Related]
15. Identification of chromosome intervals from 129 and C57BL/6 mouse strains linked to the development of systemic lupus erythematosus. Heidari Y; Bygrave AE; Rigby RJ; Rose KL; Walport MJ; Cook HT; Vyse TJ; Botto M Genes Immun; 2006 Oct; 7(7):592-9. PubMed ID: 16943797 [TBL] [Abstract][Full Text] [Related]
16. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. Korb LC; Ahearn JM J Immunol; 1997 May; 158(10):4525-8. PubMed ID: 9144462 [TBL] [Abstract][Full Text] [Related]
17. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells. Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280 [TBL] [Abstract][Full Text] [Related]
18. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity. Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288 [TBL] [Abstract][Full Text] [Related]
19. Complement component c1q and anti-c1q antibodies in theory and in clinical practice. Potlukova E; Kralikova P Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591 [TBL] [Abstract][Full Text] [Related]
20. Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination? Gillmore JD; Hutchinson WL; Herbert J; Bybee A; Mitchell DA; Hasserjian RP; Yamamura K; Suzuki M; Sabin CA; Pepys MB Immunology; 2004 Jun; 112(2):255-64. PubMed ID: 15147569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]